Synapse - Thomas Kaley

Results (156)

Bevacizumab in multiply recurrent aggressive meningiomas

Meeting Abstract

Nayak, L.; Iwamoto, F. M.; Rudnick, J. D.; Norden, A. D.; Omuro, A.; Kaley, T. J.
Neuro-Oncology (2011)

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma

Meeting Abstract

Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
Neuro-Oncology (2011)

Fulltext@MSK | Save

Preliminary results from a multicenter, phase II, randomized, non-comparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma

Meeting Abstract

Alexander, B. M.; Quant, E. C.; Batchelor, T. B.; Schiff, D. S.; Kaley, T. J.; Drappatz, J.; Wong, E. T.; Mikkelsen, T.; Weiss, S. E.; Wen, P. Y.
International Journal of Radiation Oncology, Biology, Physics (2011)

Fulltext@MSK | Save

Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial

Meeting Abstract

Kaley, T. J.; Raizer, J. J.; Paleologos, N.; Kewalramani, T.; Grimm, S.; Louis, D. N.; Cairncross, J. G.; Abrey, L. E.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Therapy of chemotherapy-induced peripheral neuropathy

Journal Article

Kaley, T. J.; Deangelis, L. M.
British Journal of Haematology (2009)

Fulltext@MSK | Save

Phase II trial of sunitinib (su011248) in patients with recurrent or inoperable meningioma

Meeting Abstract

Kaley, T.; Wen, P.; Karimi, S.; Lieberman, F.; Schiff, D.; Abrey, L.
Neuro-Oncology (2008)

Fulltext@MSK | Save